Actovegin 200 mg 50 tablets
Sildenafil 100 mg 20 tablets
Plaquenil 200 mg 60 tablets
Tamiflu 75 mg 10 capsules
Sialis 5 mg 14 tablets
Hypoxen 250 mg 30 capsules
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
Piracetam 800 mg 30 tablets
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Memantine 10 mg 30 tablets
Convulex 300 mg 50 tablets
Noopept 10 mg 50 tablets
Stugeron 25mg 50 tablets
Baclosan 25 mg 50 tablets
Tidomet forte 100 tablets
Neurontin 300 mg 50 capsules
Vinpotropil 30 capsules
Persen night 40 capsules
Sermion 10 mg 50 tablets
Actovegin 2 ml 25 vials
Actovegin 5 ml 5 vials
Mirapex 1.5 mg 30 tablets
Mirapex 0.375 mg 10 tablets
Mydocalm 50 mg 30 tablets
encephabol 100 mg 50 tablets
Pronoran 50 mg 30 tablets
Ceraxon 1000 mg/4 ml 5 vials
Ginos 40 mg 30 tablets
Cerebrolysin 2 ml 10 vials
Trileptal 150 mg 50 tablets
Deprim 30 tablets
Supirocin 2% 15 g ointment for external use
Manufacturer: GLENMARK.
Country of origin: India
General description: Antibiotic
Composition
100 g of ointment contains: Active substance: mupirocin - 2 g. Excipients: Macrogol 400 (polyethylene glycol 400), macrogol 4000 (polyethylene glycol 4000).
Pharmachologic effect
Mupirocin is an antibiotic produced by the microorganism Pseudomonas fluorescens. Mupirocin inhibits bacterial cell protein synthesis by reversible binding to isoleucyl-transport RNA synthetase, which prevents the inclusion of isoleukin in the protein chains under construction. When used in minimal inhibitory concentrations, mupirocin has bacteriostatic, and at higher concentrations, bactericidal action. Due to a specific mechanism of action and a unique chemical structure, there is no cross-resistance with other antibiotics. With the correct application of mupirocin, the risk of the emergence of resistant strains of microorganisms is small. The spectrum of antibacterial activity in vitro: Gram-positive aerobes: Staphylococcus aureus (including strains resistant to methicillin and producing beta-lactamases), Staphylococcus epidermidis, Staphylococcus species, Coagulase-negative Staphylococcus; Gram-negative anaerobes: Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Branhamella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Bordetella pertussis; Insensitive: Corynebacterium species, Enterobacteriaceae, Gram-negative non-fermenting sticks, Micrococcus.
Indications
Primary and secondary infectious skin lesions caused by microorganisms susceptible to mupirocin, including: 1. Primary skin infections: -impetigo, -folliculitis, -furunculosis (including furuncles of external auditory canal and auricle), -ectiles; 2. Secondary infections: -infected eczema, -infected injuries (abrasions, insect bites, wounds, burns).


.